Searched for
PHARMA BUSINESS DEMERGER
Vedanta demerger: What recent large demergers of Tata Motors, ITC and others tell us about possible listing timeline?Vedanta's mega demerger has created four new entities, with investors eagerly awaiting their stock market listings. Drawing parallels from ...- Vedanta demerger: When will the four new stocks list on NSE, BSE? Here's what investors can expectVedanta’s demerger has left investors awaiting the listing of its four newly carved-out entities, even as the parent stock continues to ris...
- Vedanta demerger: When will the four new stocks list on BSE, NSE? Here’s what recent demergers indicateMining giant Vedanta is set to demerge four businesses into separate listed entities, with May 1 as the record date. Shareholders will rece...
- Stocks in news: RIL, IDFC First Bank, Paytm, Sun Pharma, Manappuram FinanceIndian markets faced pressure extending a corrective phase. Key companies like RIL, IDFC First Bank, and Paytm reported their financial res...
- Strides Pharma to spin off CDMO assets to form a separate unitPharmaceutical company Strides Pharma is planning to demerge its contract development and manufacturing services (CDMO) assets into an asso...
- Piramal Pharma gets locked in lower circuitThe Ajay Piramal entity’s listing follows the demerger from parent Piramal Enterprises (PEL) as part of an exercise to simplify its structu...
- Piramal Enterprises trades ex-demerger; NBFC business lists at Rs 1,050The record date for the demerger of the pharma business from the finance business has been set as September 1 and stock traded ex-demerger ...
- Piramal shares to trade ex-demerger on TuesdayPiramal Enterprises has secured the approval of the National Company Law Tribunal (NCLT) for the demerger of its pharmaceutical business an...
- NCLT approves demerger of pharma business from Piramal EnterprisesAjay Piramal, chairperson of PEL said the company is on track to achieve the completion of demerger and separate listing of PPL by the thir...
- Ajay Piramal explains pharma business demerger, growth prospects and more“Whatever we committed to the market we have delivered and probably a little more than that. We had committed that we will bring in equity ...
- Piramal board okays demerger of pharma, financial services operationsThe amalgamation of PHL Fininvest Private Limited with PEL will create a listed non-banking financial services (NBFC) entity. The merged ho...
- Piramal Enterprise gets board nod for demerger and listing of pharma businessThe pharmaceuticals business will get vertically demerged from Piramal Enterprises and consolidated under Piramal Pharma Ltd (PPL), the gro...
- Aarti Industries board okays demerger of pharma unit; shareholders get 1 share for every 4 they own“The demerger will enable the Aarti Pharmalabs to expand its presence in the fast moving pharma business in India and abroad.It will result...
- NCLT rejects Sun Pharma’s plan to demerge overseas subsidiaryThe company had approached the Ahmedabad bench of NCLT for an approval to transfer investment undertakings from Sun Pharma to its Netherlan...
- Alembic Pharma sales up 34%, plans Brazil forayAlembic Pharmaceuticals has posted 34% rise in net sales in its first quarter result after being carved out of Alembic Ltd.
- Alembic demerges core pharma biz, forays into realtyIn a bid to separate a bleeding Penicillin-G business from its other businesses, the 103-year-old Alembic Ltd has decided to hive off its c...
- Alembic demerges pharma unit; stock up 15%Alembic has approved demerger of its pharmaceutical unit. The new entity Alembic Pharma will be listed on the exchanges post merger.
- Aurobindo, Cadila, Lupin plan to hive off R&D unitsThe move is to reduce cost pressures and improve the valuations of other businesses.
- HC approves Sun Pharma demergerSun Pharmaceuticals announced on Thursday that the Gujarat High Court had approved the company’s demerger of its ‘innovative’ research and ...
- Solvay fails to acquire more in DupharBelgian pharma group, Solvay Pharma’s move to acquire an additional 3.36 per cent stake in Duphar Pharma has run into a roadblock with the ...
Load More
